Article info
PDFEditorial
Substandard medicines: a greater problem than counterfeit medicines?
- Correspondence to Emeritus Professor Imti Choonara, Academic Unit of Child Health, University of Nottingham, Derbyshire Children’s Hospital, Derby DE22 3NE, UK; Imti.Choonara{at}nottingham.ac.uk
Citation
Substandard medicines: a greater problem than counterfeit medicines?
Publication history
- Received March 14, 2017
- Revised April 20, 2017
- Accepted April 21, 2017
- First published May 18, 2017.
Online issue publication
August 20, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/